Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Cytokinetics Inc. common stock.
Paying user area
Try for free
Cytokinetics Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cytokinetics Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Cytokinetics Inc. (CYTK) | Standard & Poor’s 500 (S&P 500) | |||||
---|---|---|---|---|---|---|
t | Date | PriceCYTK,t1 | DividendCYTK,t1 | RCYTK,t2 | PriceS&P 500,t | RS&P 500,t3 |
Jan 31, 2018 | ||||||
1. | Feb 28, 2018 | |||||
2. | Mar 31, 2018 | |||||
3. | Apr 30, 2018 | |||||
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
58. | Nov 30, 2022 | |||||
59. | Dec 31, 2022 | |||||
Average (R): | ||||||
Standard deviation: |
Cytokinetics Inc. (CYTK) | Standard & Poor’s 500 (S&P 500) | |||||
---|---|---|---|---|---|---|
t | Date | PriceCYTK,t1 | DividendCYTK,t1 | RCYTK,t2 | PriceS&P 500,t | RS&P 500,t3 |
Jan 31, 2018 | ||||||
1. | Feb 28, 2018 | |||||
2. | Mar 31, 2018 | |||||
3. | Apr 30, 2018 | |||||
4. | May 31, 2018 | |||||
5. | Jun 30, 2018 | |||||
6. | Jul 31, 2018 | |||||
7. | Aug 31, 2018 | |||||
8. | Sep 30, 2018 | |||||
9. | Oct 31, 2018 | |||||
10. | Nov 30, 2018 | |||||
11. | Dec 31, 2018 | |||||
12. | Jan 31, 2019 | |||||
13. | Feb 28, 2019 | |||||
14. | Mar 31, 2019 | |||||
15. | Apr 30, 2019 | |||||
16. | May 31, 2019 | |||||
17. | Jun 30, 2019 | |||||
18. | Jul 31, 2019 | |||||
19. | Aug 31, 2019 | |||||
20. | Sep 30, 2019 | |||||
21. | Oct 31, 2019 | |||||
22. | Nov 30, 2019 | |||||
23. | Dec 31, 2019 | |||||
24. | Jan 31, 2020 | |||||
25. | Feb 29, 2020 | |||||
26. | Mar 31, 2020 | |||||
27. | Apr 30, 2020 | |||||
28. | May 31, 2020 | |||||
29. | Jun 30, 2020 | |||||
30. | Jul 31, 2020 | |||||
31. | Aug 31, 2020 | |||||
32. | Sep 30, 2020 | |||||
33. | Oct 31, 2020 | |||||
34. | Nov 30, 2020 | |||||
35. | Dec 31, 2020 | |||||
36. | Jan 31, 2021 | |||||
37. | Feb 28, 2021 | |||||
38. | Mar 31, 2021 | |||||
39. | Apr 30, 2021 | |||||
40. | May 31, 2021 | |||||
41. | Jun 30, 2021 | |||||
42. | Jul 31, 2021 | |||||
43. | Aug 31, 2021 | |||||
44. | Sep 30, 2021 | |||||
45. | Oct 31, 2021 | |||||
46. | Nov 30, 2021 | |||||
47. | Dec 31, 2021 | |||||
48. | Jan 31, 2022 | |||||
49. | Feb 28, 2022 | |||||
50. | Mar 31, 2022 | |||||
51. | Apr 30, 2022 | |||||
52. | May 31, 2022 | |||||
53. | Jun 30, 2022 | |||||
54. | Jul 31, 2022 | |||||
55. | Aug 31, 2022 | |||||
56. | Sep 30, 2022 | |||||
57. | Oct 31, 2022 | |||||
58. | Nov 30, 2022 | |||||
59. | Dec 31, 2022 | |||||
Average (R): | ||||||
Standard deviation: |
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of CYTK during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
t | Date | RCYTK,t | RS&P 500,t | (RCYTK,t–RCYTK)2 | (RS&P 500,t–RS&P 500)2 | (RCYTK,t–RCYTK)×(RS&P 500,t–RS&P 500) |
---|---|---|---|---|---|---|
1. | Feb 28, 2018 | |||||
2. | Mar 31, 2018 | |||||
3. | Apr 30, 2018 | |||||
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
58. | Nov 30, 2022 | |||||
59. | Dec 31, 2022 | |||||
Total (Σ): |
t | Date | RCYTK,t | RS&P 500,t | (RCYTK,t–RCYTK)2 | (RS&P 500,t–RS&P 500)2 | (RCYTK,t–RCYTK)×(RS&P 500,t–RS&P 500) |
---|---|---|---|---|---|---|
1. | Feb 28, 2018 | |||||
2. | Mar 31, 2018 | |||||
3. | Apr 30, 2018 | |||||
4. | May 31, 2018 | |||||
5. | Jun 30, 2018 | |||||
6. | Jul 31, 2018 | |||||
7. | Aug 31, 2018 | |||||
8. | Sep 30, 2018 | |||||
9. | Oct 31, 2018 | |||||
10. | Nov 30, 2018 | |||||
11. | Dec 31, 2018 | |||||
12. | Jan 31, 2019 | |||||
13. | Feb 28, 2019 | |||||
14. | Mar 31, 2019 | |||||
15. | Apr 30, 2019 | |||||
16. | May 31, 2019 | |||||
17. | Jun 30, 2019 | |||||
18. | Jul 31, 2019 | |||||
19. | Aug 31, 2019 | |||||
20. | Sep 30, 2019 | |||||
21. | Oct 31, 2019 | |||||
22. | Nov 30, 2019 | |||||
23. | Dec 31, 2019 | |||||
24. | Jan 31, 2020 | |||||
25. | Feb 29, 2020 | |||||
26. | Mar 31, 2020 | |||||
27. | Apr 30, 2020 | |||||
28. | May 31, 2020 | |||||
29. | Jun 30, 2020 | |||||
30. | Jul 31, 2020 | |||||
31. | Aug 31, 2020 | |||||
32. | Sep 30, 2020 | |||||
33. | Oct 31, 2020 | |||||
34. | Nov 30, 2020 | |||||
35. | Dec 31, 2020 | |||||
36. | Jan 31, 2021 | |||||
37. | Feb 28, 2021 | |||||
38. | Mar 31, 2021 | |||||
39. | Apr 30, 2021 | |||||
40. | May 31, 2021 | |||||
41. | Jun 30, 2021 | |||||
42. | Jul 31, 2021 | |||||
43. | Aug 31, 2021 | |||||
44. | Sep 30, 2021 | |||||
45. | Oct 31, 2021 | |||||
46. | Nov 30, 2021 | |||||
47. | Dec 31, 2021 | |||||
48. | Jan 31, 2022 | |||||
49. | Feb 28, 2022 | |||||
50. | Mar 31, 2022 | |||||
51. | Apr 30, 2022 | |||||
52. | May 31, 2022 | |||||
53. | Jun 30, 2022 | |||||
54. | Jul 31, 2022 | |||||
55. | Aug 31, 2022 | |||||
56. | Sep 30, 2022 | |||||
57. | Oct 31, 2022 | |||||
58. | Nov 30, 2022 | |||||
59. | Dec 31, 2022 | |||||
Total (Σ): |
Show all
VarianceCYTK = Σ(RCYTK,t–RCYTK)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceCYTK, S&P 500 = Σ(RCYTK,t–RCYTK)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
VarianceCYTK | |
VarianceS&P 500 | |
CovarianceCYTK, S&P 500 | |
Correlation coefficientCYTK, S&P 5001 | |
βCYTK2 | |
αCYTK3 |
Calculations
1 Correlation coefficientCYTK, S&P 500
= CovarianceCYTK, S&P 500 ÷ (Standard deviationCYTK × Standard deviationS&P 500)
= ÷ ( × )
=
2 βCYTK
= CovarianceCYTK, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αCYTK
= AverageCYTK – βCYTK × AverageS&P 500
= – ×
=
Expected Rate of Return
Assumptions | ||
Rate of return on LT Treasury Composite1 | RF | |
Expected rate of return on market portfolio2 | E(RM) | |
Systematic risk (β) of Cytokinetics Inc. common stock | βCYTK | |
Expected rate of return on Cytokinetics Inc. common stock3 | E(RCYTK) |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RCYTK) = RF + βCYTK [E(RM) – RF]
= + [ – ]
=